ZBH(Zimmer Biomet Holdings, Inc.) 的财务报表:医疗保健,医疗器械。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $6.83B | $6.94B | $7.39B | $7.68B | $8.23B |
| 毛利润 | $4.87B | $4.92B | $5.31B | $5.49B | $5.74B |
| 营业利润 | $860.30M | $696.30M | $1.28B | $1.29B | $1.10B |
| 净利润 | $401.60M | $231.40M | $1.02B | $903.80M | $705.10M |
| 经营现金流 | $1.50B | $1.36B | $1.58B | $1.50B | $1.70B |
| 自由现金流 | $1.36B | $1.17B | $1.29B | $1.30B | $1.47B |
| 摊薄每股收益 | $1.91 | $1.10 | $4.88 | $4.43 | $3.55 |